CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
04 06 2019
Historique:
received: 04 11 2017
accepted: 09 05 2019
entrez: 6 6 2019
pubmed: 6 6 2019
medline: 18 6 2019
Statut: epublish

Résumé

Tumor-associated myeloid cells regulate tumor growth and metastasis, and their accumulation is a negative prognostic factor for breast cancer. Here we find calcium/calmodulin-dependent kinase kinase (CaMKK2) to be highly expressed within intratumoral myeloid cells in mouse models of breast cancer, and demonstrate that its inhibition within myeloid cells suppresses tumor growth by increasing intratumoral accumulation of effector CD8

Identifiants

pubmed: 31164648
doi: 10.1038/s41467-019-10424-5
pii: 10.1038/s41467-019-10424-5
pmc: PMC6547743
doi:

Substances chimiques

Chemokines 0
CAMKK2 protein, human EC 2.7.11.17
Calcium-Calmodulin-Dependent Protein Kinase Kinase EC 2.7.11.17
Camkk2 protein, mouse EC 2.7.11.17

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

2450

Subventions

Organisme : Susan G. Komen (Susan G. Komen Breast Cancer Foundation)
ID : IIR13264868
Pays : International
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : R01CA174643
Pays : International
Organisme : United States Department of Defense | United States Army | U.S. Army Corps of Engineers (US Army Corps of Engineers)
ID : CA140307
Pays : International
Organisme : NIH HHS
ID : S10 OD018164
Pays : United States
Organisme : U.S. Department of Health & Human Services | National Institutes of Health (NIH)
ID : R00CA172357
Pays : International

Références

Science. 2014 May 23;344(6186):921-5
pubmed: 24812208
Cancer Res. 2008 Oct 15;68(20):8437-45
pubmed: 18922917
Cancer Res. 2011 Jan 15;71(2):528-37
pubmed: 21098087
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2491-6
pubmed: 22308361
J Biol Chem. 2012 Mar 30;287(14):11579-91
pubmed: 22334678
Oncotarget. 2015 Apr 10;6(10):7944-58
pubmed: 25760243
J Breast Cancer. 2016 Mar;19(1):34-44
pubmed: 27066094
J Immunol. 2018 Aug 15;201(4):1306-1314
pubmed: 29997124
Science. 2011 Mar 25;331(6024):1565-70
pubmed: 21436444
Trends Endocrinol Metab. 2016 Oct;27(10):706-718
pubmed: 27449752
Nat Commun. 2016 Dec 23;7:13720
pubmed: 28008905
Nat Commun. 2017 Oct 11;8(1):864
pubmed: 29021522
Nature. 2017 May 25;545(7655):495-499
pubmed: 28514441
J Clin Invest. 2011 Dec;121(12):4903-15
pubmed: 22080866
Mol Cell Biol. 2002 Jan;22(1):23-9
pubmed: 11739719
J Clin Invest. 2015 Sep;125(9):3365-76
pubmed: 26325033
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Trends Immunol. 2008 Dec;29(12):600-7
pubmed: 18930438
PLoS One. 2016 Mar 03;11(3):e0150606
pubmed: 26938654
Hum Pathol. 2007 Nov;38(11):1628-38
pubmed: 17521701
Nat Methods. 2015 May;12(5):453-7
pubmed: 25822800
Cancer Immunol Immunother. 2010 Nov;59(11):1715-26
pubmed: 20706716
EMBO J. 2011 May 20;30(13):2719-33
pubmed: 21602788
Genes Dev. 2007 Aug 1;21(15):1909-20
pubmed: 17671090
Subcell Biochem. 2007;45:169-214
pubmed: 18193638
Oncoimmunology. 2015 Oct 29;5(3):e1091554
pubmed: 27141352
Cell Rep. 2016 May 31;15(9):2000-11
pubmed: 27210762
J Biol Chem. 2017 Aug 25;292(34):14188-14204
pubmed: 28634229
Cancer Res. 2010 Jul 15;70(14):5728-39
pubmed: 20570887
J Clin Pathol. 2012 Feb;65(2):159-63
pubmed: 22049225
J Immunol. 2008 Dec 15;181(12):8633-41
pubmed: 19050283
J Leukoc Biol. 2009 Nov;86(5):1065-73
pubmed: 19741157
Cancer Res. 1996 Oct 15;56(20):4625-9
pubmed: 8840975
Cell Metab. 2013 Aug 6;18(2):251-64
pubmed: 23931756
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
Cell Signal. 2011 Dec;23(12):2005-12
pubmed: 21807092
Hepatology. 2015 Aug;62(2):505-20
pubmed: 25847065
J Leukoc Biol. 2011 Nov;90(5):897-909
pubmed: 21816924
Cell Death Dis. 2017 Oct 5;8(10):e3076
pubmed: 28981105
NPJ Breast Cancer. 2016;2:
pubmed: 26998515
J Interferon Cytokine Res. 2009 Feb;29(2):83-92
pubmed: 19014340
J Clin Invest. 2015 Oct 26;125(12):4334-48
pubmed: 26517695
Science. 2013 Nov 29;342(6162):1094-8
pubmed: 24288332
Breast Cancer Res Treat. 2007 Jul;103(3):283-91
pubmed: 17260099
Cancer Biol Ther. 2015;16(2):336-45
pubmed: 25756516
Cancer Cell. 2013 Nov 11;24(5):589-602
pubmed: 24209604
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Blood. 2008 Jan 15;111(2):723-31
pubmed: 17909078
Nature. 2015 Nov 12;527(7577):249-53
pubmed: 26503055
J Leukoc Biol. 2013 Dec;94(6):1113-21
pubmed: 23883517
Curr Opin Immunol. 2017 Apr;45:43-51
pubmed: 28192720
Sci Rep. 2017 Apr 24;7(1):1093
pubmed: 28439087
Trends Cancer. 2018 Nov;4(11):784-792
pubmed: 30352680
Nat Commun. 2015 Jun 25;6:7458
pubmed: 26109379
BMC Immunol. 2011 Aug 04;12:43
pubmed: 21813021
Nature. 2003 Oct 30;425(6961):917-25
pubmed: 14586460
BMC Cancer. 2012 Jul 23;12:306
pubmed: 22824040
Immunity. 2014 Jul 17;41(1):49-61
pubmed: 25035953
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Cancer Cell. 2014 Nov 10;26(5):623-37
pubmed: 25446896
J Immunol. 2015 Jan 15;194(2):584-94
pubmed: 25512602
Cancer. 1952 Mar;5(2):382-402
pubmed: 14905426
J Biol Chem. 2012 Sep 14;287(38):31658-65
pubmed: 22778263
Trends Mol Med. 2013 Feb;19(2):83-8
pubmed: 23332598
Curr Protoc Immunol. 2009 Aug;Chapter 3:Unit 3.7
pubmed: 19653207
Oncotarget. 2016 Jul 12;7(28):44288-44298
pubmed: 27329588
J Biol Chem. 2010 Jun 18;285(25):19051-9
pubmed: 20421294
Cell Metab. 2008 May;7(5):377-88
pubmed: 18460329

Auteurs

Luigi Racioppi (L)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA. luigi.racioppi@duke.edu.
Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, 80131, Italy. luigi.racioppi@duke.edu.

Erik R Nelson (ER)

Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
University of Illinois Cancer Center, Chicago, IL, 60612, USA.
Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.

Wei Huang (W)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA.

Debarati Mukherjee (D)

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.

Scott A Lawrence (SA)

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.
Eli Lilly and Company, Indianapolis, IN, 46285, USA.

William Lento (W)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA.

Anna Maria Masci (AM)

Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, 27710, USA.

Yiquin Jiao (Y)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA.

Sunghee Park (S)

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.

Brian York (B)

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Yaping Liu (Y)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA.

Amy E Baek (AE)

Molecular and Integrative Physiology, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.

David H Drewry (DH)

Department of Chemical Biology, GlaxoSmithKline, Research Triangle Park, NC, 27709, USA.
UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, USA.

William J Zuercher (WJ)

Department of Chemical Biology, GlaxoSmithKline, Research Triangle Park, NC, 27709, USA.
UNC Eshelman School of Pharmacy, Chapel Hill, NC, 27599, USA.

Francesca R Bertani (FR)

CNR IFN Institute for Photonics and Nanotechnologies, Rome, 00156, Italy.

Luca Businaro (L)

CNR IFN Institute for Photonics and Nanotechnologies, Rome, 00156, Italy.

Joseph Geradts (J)

Department of Population Sciences, City of Hope National Medical Center, Duarte, CA, 91010, USA.
Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.

Allison Hall (A)

Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.

Anthony R Means (AR)

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA.

Nelson Chao (N)

Department of Medicine, Division of Hematological Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC, 27710, USA.

Ching-Yi Chang (CY)

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA.

Donald P McDonnell (DP)

Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, 27710, USA. Donald.McDonnell@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH